OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates

Company Performance - OraSure Technologies reported a quarterly loss of $0.01 per share, better than the Zacks Consensus Estimate of a loss of $0.04, and a significant decline from earnings of $0.27 per share a year ago, indicating a 103.7% decrease year-over-year [1] - The company achieved revenues of $39.92 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 1.97%, but down from $89.19 million in the same quarter last year, reflecting a 55.2% decline [2] - Over the last four quarters, OraSure has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Performance - OraSure shares have declined approximately 47.7% since the beginning of the year, contrasting with the S&P 500's gain of 21.2% [3] - The current Zacks Rank for OraSure is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is -$0.03 on revenues of $38.51 million, while for the current fiscal year, the estimate is $0.05 on revenues of $186.12 million [7] - The outlook for the Medical - Products industry, to which OraSure belongs, is currently in the top 36% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]